Prognostic [<sup>68</sup>Ga]Ga‐PSMA‐11 PET Biomarkers for [<sup>177</sup>Lu]Lu‐PSMA Radioligand Therapy in Metastatic Castrate‐Resistant Prostate Cancer (Asian Population Study)
PSMA-TLQ and PSMA-TV were negative prognostic markers and SUVmean was a positive prognostic marker among Asian patients with mCRPC who received [<sup>177</sup>Lu]Lu-PSMA radioligand therapy.
Authors
- Winnie Lam (ORCID: https://orcid.org/0000-0002-9813-9857)
- Ravindran Kanesvaran (ORCID: https://orcid.org/0000-0002-2351-881X)
- Sue Ping Thang (ORCID: https://orcid.org/0000-0002-7229-8737)
- Alvin Wong (ORCID: https://orcid.org/0000-0002-2020-9624)
- Kenneth Chen (ORCID: https://orcid.org/0000-0002-3844-7567)
- Wei Chua (ORCID: https://orcid.org/0000-0002-2021-3586)
- N. Koh
- Aaron Kian Ti Tong (ORCID: https://orcid.org/0000-0002-7703-8707)
Institutions
- SingHealth (SG)
- Singapore General Hospital (SG)
- SingHealth Duke-NUS Academic Medical Centre (SG)
- National University Cancer Institute, Singapore (SG)
- Duke-NUS Medical School (SG)
- National Cancer Centre Singapore (SG)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1111/ajco.14174
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52